MedTrace Logo

Feasibility Study of Project Carer Matters for Family Caregivers of Persons With Dementia

NCT05205135 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 55

Last updated 2022-01-24

No results posted yet for this study

Summary

The study uses the Reach, Effectiveness, Adoption, Implementation and Maintenance (RE-AIM) framework to assess the Carer Matters programme for dementia caregivers in Singapore. A parallel mixed-methods study design is applied to assess the programme's feasibility and effectiveness.

Conditions

  • Caregivers
  • Caregiver Burden
  • Caregiver Burnout
  • Dementia

Interventions

BEHAVIORAL

SHARE Programme

SHARE is Singapore's first 'Hospital-to-Home' programme to screen, identify and provide targeted interventions for caregivers at-risk of caregiver burden. Our interventions include psychosocial and emotional preparation of caregivers' mental resilience, and long-term engagement initiatives to connect caregivers into an integrated network of peers and community support services, delivered by programme facilitators and care support nurses. Key stakeholders essential for the success of share include ward nurses and clinicians who refer caregivers to SHARE and community partners and hospital leaders. This study seeks to recruit all of these individuals to better understand their experience of SHARE and the facilitators and barriers to its successful rollout to better evaluate the feasibility of SHARE in the hospital to home setting.

Sponsors & Collaborators

  • Geriatric Education and Research Institute

    collaborator OTHER_GOV

  • Tan Tock Seng Hospital

    lead OTHER

Principal Investigators

  • Ee Yuee Chan, PhD · Tan Tock Seng Hospital

Eligibility

Min Age
21 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-03-01
Primary Completion
2021-11-30
Completion
2022-02-01

Countries

  • Singapore

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05205135 on ClinicalTrials.gov